FDA
-
FDA selects first 5 participants for READI-Home initiative
The innovation challenge is focused on developing home devices that could help reduce hospital readmissions.
By Elise Reuter • Oct. 1, 2026 -
Medtronic reveals cardiac mapping and ablation software clearances
The regulatory authorizations come as Medtronic looks to differentiate itself in the fast-growing pulsed field ablation market targeted by rivals Abbott, Boston Scientific and J&J.
By Nick Paul Taylor • Oct. 1, 2026 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
FDA issues draft guidance for surgical robots
A two-day public workshop on evaluating robotic surgery systems with autonomous or remote capabilities is also on the agency’s agenda, as telesurgery advances globally.
By Susan Kelly • Sept. 28, 2026 -
Anastasiia. Retrieved from Adobe Stock.
Sponsored by MedtronicThe Next Evolution of TLIF: Where Innovation Meets Clinical Evidence
New evidence, FDA approval, and Medicare NTAP status expand Infuse™ bone graft use in TLIF.
By Sara Rivera, VP, Clinical Cranial & Spinal Technologies, Medtronic • Sept. 28, 2026 -
FDA nominee Overton parries vaccine questions at Senate hearing
Pressed by lawmakers on Thursday, Trump’s pick as the next FDA chief said she’d “follow the law” on key decisions and work to speed early drug research.
By Jonathan Gardner • Sept. 24, 2026 -
Grail multicancer detection test wins FDA advisers’ backing
Members of the molecular and clinical genetics panel said the first-of-a-kind blood test should not be used to replace medical guideline-recommended cancer screenings.
By Susan Kelly • Sept. 24, 2026 -
Cordis wins FDA approval for sirolimus-eluting balloon
The approval gives physicians an alternative to uncoated balloons and Boston Scientific’s paclitaxel-coated device.
By Nick Paul Taylor • Sept. 22, 2026 -
Cognita Imaging wins FDA contract to test LLMs in evaluating radiology AI
Cognita’s method will test a way of evaluating AI-generated radiology reports as the FDA considers how to regulate generative AI-enabled devices.
By Elise Reuter • Sept. 18, 2026 -
Neptune Medical secures FDA nod for endoscopy robot
The robot is intended to give physicians more control of the endoscope during a colonoscopy procedure, which can help with detection and removal of lesions.
By Susan Kelly • Sept. 18, 2026 -
FDA clears vessel-sealing device for Medtronic’s Hugo robot
Widely adopted in open and laparoscopic surgeries, the LigaSure instrument is now available for use with the Hugo robotic system.
By Nick Paul Taylor • Sept. 17, 2026 -
Sponsored by IQVIA MedTech
Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions
FDA’s eSTAR framework raises the bar for documenting human factors and use-related risk.
By Di Lu, Associate Director, Regulatory Affairs | Human Factors and Usability Engineering at IQVIA MedTech • Sept. 14, 2026 -
Deep Dive
4 questions about the FDA’s approach to generative AI
The medtech industry is awaiting FDA guidance on generative AI. The agency has sought feedback in advisory meetings and a discussion paper as the technology becomes more prevalent.
By Elise Reuter • Sept. 9, 2026 -
Abbott wins FDA approval for dual-energy ablation catheter
CEO Robert Ford has said the atrial fibrillation treatment, along with the company's Volt PFA device, is expected to help Abbott regain market share in electrophysiology.
By Susan Kelly • Sept. 8, 2026 -
Boston Scientific recall of spinal cord stimulator leads tied to more than 1,000 injuries
A problem with the leads could cause inadequate stimulation, Boston Scientific said. In the worst case, leads may need to be removed or replaced.
By Susan Kelly • Sept. 4, 2026 -
Medtronic recalls pH monitoring capsule linked to 184 serious injuries
For the second time in two years, Medtronic has pulled capsules from the market over a fault that could obstruct patients’ airways.
By Nick Paul Taylor • Aug. 28, 2026 -
J&J’s latest Impella recall tied to 3 deaths, 37 injuries
Hospitals can use automated controllers in inventory while waiting for service from J&J’s Abiomed business to ensure patients who need Impella heart pumps can still receive care.
By Susan Kelly • Aug. 27, 2026 -
National Institute on Aging. (2017). "Beta-Amyloid Plaques and Tau in the Brain" [Image]. Retrieved from Flickr.
Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test
Labcorp and Quest Diagnostics both plan to offer the test, which secured CE mark certification earlier this year.
By Susan Kelly • Aug. 25, 2026 -
FDA adds two behavioral health firms to TEMPO pilot
Sondermind and Limbic are evaluating digital health devices intended to help with anxiety and depression.
By Elise Reuter • Aug. 24, 2026 -
How can wearables be used in clinical trials? FDA outlines best practices
Digital health technologies used in studies should be validated and measure outcomes that matter to patients, the FDA said.
By Elise Reuter • Aug. 21, 2026 -
Vitestro secures FDA nod for robotic blood draw device
The Food and Drug Administration hailed the potential of the first-of-its-kind device to counter the U.S. phlebotomist shortage.
By Nick Paul Taylor • Aug. 20, 2026 -
Trump nominates policy aide Overton to lead FDA
Heidi Overton, a medical doctor and veteran of the America First think tank, currently serves as deputy director of the White House Domestic Policy Council.
By Kristin Jensen • Aug. 19, 2026 -
FDA seeks feedback on generative AI regulations
The agency published a discussion paper this week as it considers the “unique risks” and potential promise of generative AI for patient care.
By Elise Reuter • Aug. 19, 2026 -
FDA names second participant in TEMPO digital health pilot
Cadence, a company that makes AI-enabled software to support hypertension management, will join the pilot, which allows companies to collect real-world data through Medicare.
By Elise Reuter • Aug. 17, 2026 -
Device firms back latest MDUFA deal, while patients want more postmarket safety
The latest agreement includes higher fees for overseas firms, hiring transparency requirements and greater use of real-world evidence.
By Elise Reuter • Aug. 10, 2026 -
FDA sets advisory panel for Galleri multicancer screening test
Outside experts will convene in September to review Grail’s premarket approval application for the MCED blood test. Experts selected for the committee will be key to watch, an analyst said.
By Susan Kelly • Aug. 7, 2026